Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in ovarian cancer
- PMID: 22335024
Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in ovarian cancer
Abstract
Calpains, also called calcium activated neutral proteases (CANP), are expressed ubiquitously. They are intracellular, non-lysosomal cytoplasmic cysteine endopeptidases. Calcium is required for their activation. Their endogenous specific inhibitor is calpastatin, which is expressed ubiquitously and coexists within cells besides calpain. When calcium is present, calpastatin and calpain attach to each other inhibiting the protease. The calpain system plays an important role in many processes including apoptosis, necrosis, ischemia formation and exocytosis. So far, many reports exist on studies about the influence of calpains in different tumors (skin, breast, renal cell and prostate cancers). The role of calpains in pathogenesis or further tumor progression has always been proved in related studies, but their exact function could not be demonstrated. So far, no studies on calpains being involved in the pathogenesis of ovarian cancer have been published. In our study we focused on the expression of the enzymes calpain 1, calpain 2 and their inhibitor calpastatin in normal and malign ovarian tissue. Therefore, we performed immunohistochemical stainings of paraffin slices and evaluated staining intensity (SI), percentage of positive cells (PP) and immunoreactive score (IRS). We evaluated the correlation between enzyme expression in malign and benign ovarian tissues. In malignant ovarian tissue, we found decreased expression, staining intensity and immunoreactive score of calpastatin. With higher grading of the ovarian carcinoma, staining intensity and immunoreactive score of calpain 1 decreased. Staining intensity of calpain 2 in ovarian carcinoma decreased with increasing lymph node status. We clearly demonstrated differences between enzyme expressions in malign and benign tissue. This study could not find any specific function of calpains. Only few studies in the literature have been found that deal with calpain evaluation of ovarian cancer. Additional studies including more patients are required to elucidate the functional role and impact of calpain in tumors in detail.
Similar articles
-
Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in endometrial cancer.Anticancer Res. 2010 Jul;30(7):2837-43. Anticancer Res. 2010. PMID: 20683020
-
Reversed distribution of calpains and calpastatin in human pituitary gland and selective localization of calpastatin in adrenocorticotropin-producing cells as demonstrated by immunohistochemistry.J Clin Endocrinol Metab. 1986 Aug;63(2):343-8. doi: 10.1210/jcem-63-2-343. J Clin Endocrinol Metab. 1986. PMID: 2424927
-
Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord.J Neurobiol. 1996 Jun;30(2):177-91. doi: 10.1002/(SICI)1097-4695(199606)30:2<177::AID-NEU1>3.0.CO;2-2. J Neurobiol. 1996. PMID: 8738748
-
Calpain in Breast Cancer: Role in Disease Progression and Treatment Response.Pathobiology. 2015 Sep;82(3-4):133-41. doi: 10.1159/000430464. Epub 2015 Aug 31. Pathobiology. 2015. PMID: 26330354 Review.
-
[Calpain and calpastatin].Rinsho Byori. 1990 Apr;38(4):337-46. Rinsho Byori. 1990. PMID: 2195187 Review. Japanese.
Cited by
-
BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.Cell Cycle. 2015;14(12):1884-92. doi: 10.1080/15384101.2015.1036203. Cell Cycle. 2015. PMID: 25927284 Free PMC article.
-
Calpain system protein expression and activity in ovarian cancer.J Cancer Res Clin Oncol. 2019 Feb;145(2):345-361. doi: 10.1007/s00432-018-2794-2. Epub 2018 Nov 17. J Cancer Res Clin Oncol. 2019. PMID: 30448882 Free PMC article.
-
Towards an animal model of ovarian cancer: cataloging chicken blood proteins using combinatorial peptide ligand libraries coupled with shotgun proteomic analysis for translational research.OMICS. 2014 May;18(5):280-97. doi: 10.1089/omi.2013.0164. Epub 2014 Mar 24. OMICS. 2014. PMID: 24660652 Free PMC article.
-
E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer.Br J Cancer. 2016 Jan 19;114(2):213-20. doi: 10.1038/bjc.2015.436. Br J Cancer. 2016. PMID: 26757261 Free PMC article.
-
Screening aberrant methylation profile in esophageal squamous cell carcinoma for Kazakhs in Xinjiang area of China.Mol Biol Rep. 2015 Feb;42(2):457-64. doi: 10.1007/s11033-014-3788-z. Epub 2014 Oct 11. Mol Biol Rep. 2015. PMID: 25304811
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous